LA JOLLA, CA – Vedolizumab (sold under the trade name Entyvio®) is a medication that is used to treat Crohn’s disease and ulcerative colitis, which are two forms of inflammatory bowel disease (IBD). For women who became pregnant while taking vedolizumab, there are limited data on whether this medication could affect the pregnancy and the developing baby. Our study sought to examine this question by evaluating the safety/risk of vedolizumab use in pregnant women who were participating in …
Press Releases: OTIS
MotherToBaby Secures Vital Funding to Empower Expectant Parents and Address Birth Defects
MotherToBaby is the Leading National Resource on Exposures during Pregnancy and Breastfeeding BRENTWOOD, TN – The non-profit Organization of Teratology Information Specialists (OTIS), which provides the MotherToBaby free service, receives new funding aimed at enhancing partnerships to address birth defects, infant disorders and related conditions, and the health of pregnant and postpartum people. The grant is supported by the Centers for Disease Control and Prevention (CDC). The funding is …
MotherToBaby Bilingual Fact Sheets Now Included in the Prestigious National Library of Medicine
Non-Profit’s Expertise Recognized as Leading Resource on Exposures during Pregnancy and Breastfeeding September 21, 2022 BRENTWOOD, TN – The non-profit Organization of Teratology Information Specialists (OTIS) through its public-facing service, MotherToBaby, are now contributors to the prestigious National Library of Medicine (NLM) where more than 250 of its bilingual (English/Spanish) evidence-based fact sheets can be found on medications, vaccines, diseases, herbal supplements, …
OTIS Statement regarding Supreme Court overturning Roe v. Wade
Adopted by the OTIS Board in June 2022 The Organization of Teratology Information Specialists (OTIS) opposes laws that prevent people from making informed reproductive choices, or that seek to prevent or criminalize healthcare professionals who inform patients of scientific knowledge or reproductive options. OTIS will continue to provide confidential, evidence-based, scientifically accurate and unbiased information about exposures before and during pregnancy that allows people who are …
OTIS Statement in Support of Ukraine During this Time of Crisis
Adopted by the OTIS Board in March 2022 The Organization of Teratology Information Specialists (OTIS) stands in solidarity with the Ukrainian people and our friends and colleagues in Ukraine. We have proudly provided education and training on teratogens in Ukraine since 2003 and helped our Ukrainian colleagues to establish their own Teratology Information Service in 2017. We feel a great kinship to the many people our various members have worked with over the years and it is greatly …
